JP2024540318A5 - - Google Patents
Info
- Publication number
- JP2024540318A5 JP2024540318A5 JP2024526654A JP2024526654A JP2024540318A5 JP 2024540318 A5 JP2024540318 A5 JP 2024540318A5 JP 2024526654 A JP2024526654 A JP 2024526654A JP 2024526654 A JP2024526654 A JP 2024526654A JP 2024540318 A5 JP2024540318 A5 JP 2024540318A5
- Authority
- JP
- Japan
- Prior art keywords
- cyclohexyl
- carboxamide
- imidazole
- compound
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2116077.5 | 2021-11-09 | ||
| GB202116077 | 2021-11-09 | ||
| PCT/GB2022/052833 WO2023084206A1 (en) | 2021-11-09 | 2022-11-09 | N-(4-aminocyclohexyl)pyrimidine-4-carboxamide derivatives as cd38 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540318A JP2024540318A (ja) | 2024-10-31 |
| JP2024540318A5 true JP2024540318A5 (enExample) | 2025-11-18 |
Family
ID=84360092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526654A Pending JP2024540318A (ja) | 2021-11-09 | 2022-11-09 | Ｃｄ３８阻害剤としてのｎ－（４－アミノシクロヘキシル）ピリミジン－４－カルボキサミド誘導体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250019369A1 (enExample) |
| EP (1) | EP4430034A1 (enExample) |
| JP (1) | JP2024540318A (enExample) |
| CN (1) | CN118317955A (enExample) |
| CA (1) | CA3236793A1 (enExample) |
| WO (1) | WO2023084206A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4532483A1 (en) * | 2022-06-02 | 2025-04-09 | Aeovian Pharmaceuticals, Inc. | Cd38 modulators and uses thereof |
| WO2024254396A1 (en) * | 2023-06-07 | 2024-12-12 | Flagship Pioneering Innovations, Vi, Llc | Condensed azines as inhibitors of cyclic adp ribose hydrolase |
| WO2026000074A1 (en) * | 2024-06-25 | 2026-01-02 | Welnx Company Inc. | Use of cd38 inhibitors for reducing th2 inflammation |
| WO2026075971A1 (en) | 2024-10-01 | 2026-04-09 | Neolaia Inc. | Combination therapy for treatment of metabolic disorders and inflamation related disorders using incretin compounds and cd38 inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2022001019A (es) | 2019-07-31 | 2022-02-22 | Ribon Therapeutics Inc | Amidas heterobiciclicas como inhibidoras del cumulo de diferenciacion 38 (cd38). |
| CN115697985B (zh) * | 2020-04-07 | 2025-01-21 | 米托布里奇公司 | Cd38抑制剂 |
| WO2022228496A1 (en) * | 2021-04-30 | 2022-11-03 | Nanjing Immunophage Biotech Co., Ltd | Compounds and their uses as cd38 inhibitors |
-
2022
- 2022-11-09 WO PCT/GB2022/052833 patent/WO2023084206A1/en not_active Ceased
- 2022-11-09 CN CN202280073666.2A patent/CN118317955A/zh active Pending
- 2022-11-09 JP JP2024526654A patent/JP2024540318A/ja active Pending
- 2022-11-09 CA CA3236793A patent/CA3236793A1/en active Pending
- 2022-11-09 EP EP22805932.5A patent/EP4430034A1/en active Pending
- 2022-11-09 US US18/708,486 patent/US20250019369A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024540318A5 (enExample) | ||
| DE60005560T2 (de) | Neuartiger p2x 7 rezeptor-antagonisten zur verwendung in der behandlung von entzündlichen, immuninduzierten erkrankungen oder erkrankungen des herz-kreislauf-systems | |
| TWI583681B (zh) | 胺基嘧啶基化合物 | |
| EP3209656B1 (en) | Indole carboxamides compounds useful as kinase inhibitors | |
| JP2006526617A5 (enExample) | ||
| JP2010518026A5 (enExample) | ||
| CA3224467A1 (en) | Phenyl acetamide based il-17a modulators and uses thereof | |
| JP6254075B2 (ja) | カリウムチャネル遮断剤としてのアミン誘導体 | |
| DE69516867T2 (de) | Piperazinderivate als 5 ht1a antagonisten | |
| WO1999019301A1 (en) | Piperazine compounds and medicinal use thereof | |
| JP2011063620A (ja) | ピペリジンおよびピペラジン誘導体 | |
| JPWO1999019301A1 (ja) | ピペラジン化合物およびその医薬としての用途 | |
| HRP20180973T1 (hr) | Supstituirani tiazolski ili oksazolski antagonisti p2x7 receptora | |
| JP2018522925A5 (enExample) | ||
| JP2010524907A (ja) | トリアゾロピリジンカルボキサミド誘導体、その調製およびその治療的使用 | |
| JP7386576B2 (ja) | Ｎ－（１ｈ－イミダゾール－２－イル）ベンズアミド化合物および該化合物を活性成分として含む医薬組成物 | |
| TWI687396B (zh) | N-[4-(1-胺基乙基)苯基]磺醯胺衍生物掌性解析之方法 | |
| IL279920B2 (en) | Bicyclic inhibitors of histone deacetylase | |
| US20140350250A1 (en) | Therapeutic agent for cerebral infarction | |
| WO2017119666A1 (ko) | 극성 비양자성 용매를 이용한 n-[4-(1-아미노에틸)-페닐]-술폰아미드 유도체의 카이랄 분할 방법 | |
| JP2025506729A5 (enExample) | ||
| JP2009520000A (ja) | カンナビノイドｃｂ１受容体モジュレーターとしての４，５−ジヒドロ−（１ｈ）−ピラゾール誘導体 | |
| EP1506187A1 (de) | 2-thio-substituierte imidazolderivate und ihre verwendung in der pharmazie | |
| JP2023507508A5 (enExample) | ||
| EP4538259A1 (en) | Processes for the preparation of deucravacitinib |